Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker KRSA
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 5, 2026 | KRSA Korsana Biosciences, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Sep 11, 2026 | KRSA Korsana Biosciences, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 11, 2026 | KRSA Korsana Biosciences, Inc. | 5.06 Change in Shell Company Status | 8-K | 8-K ↗ |
| Sep 11, 2026 | KRSA Korsana Biosciences, Inc. | 5.05 Amendments to the Code of Ethics, or Waiver of a Provision | 8-K | 8-K ↗ |
| Sep 11, 2026 | KRSA Korsana Biosciences, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Sep 11, 2026 | KRSA Korsana Biosciences, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Sep 11, 2026 | KRSA Korsana Biosciences, Inc. | 5.01 Changes in Control of Registrant | 8-K | 8-K ↗ |
| Sep 11, 2026 | KRSA Korsana Biosciences, Inc. | 3.03 Material Modification to Rights of Security Holders | 8-K | 8-K ↗ |
| Sep 11, 2026 | KRSA Korsana Biosciences, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Sep 11, 2026 | KRSA Korsana Biosciences, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Sep 11, 2026 | KRSA Korsana Biosciences, Inc. | 2.01 Completion of Acquisition or Disposition of Assets | 8-K | 8-K ↗ |
| Sep 11, 2026 | KRSA Korsana Biosciences, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Aug 27, 2026 | KRSA Korsana Biosciences, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 27, 2026 | KRSA Korsana Biosciences, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Aug 25, 2026 | KRSA Korsana Biosciences, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Apr 1, 2026 | KRSA Korsana Biosciences, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Apr 1, 2026 | KRSA Korsana Biosciences, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Apr 1, 2026 | KRSA Korsana Biosciences, Inc. | 5.01 Changes in Control of Registrant | 8-K | 8-K ↗ |
| Apr 1, 2026 | KRSA Korsana Biosciences, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Feb 17, 2026 | KRSA Korsana Biosciences, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 6, 2026 | KRSA Korsana Biosciences, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 6, 2026 | KRSA Korsana Biosciences, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Dec 1, 2025 | KRSA Korsana Biosciences, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Sep 23, 2025 | KRSA Korsana Biosciences, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 23, 2025 | KRSA Korsana Biosciences, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jun 18, 2025 | KRSA Korsana Biosciences, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 7, 2025 | KRSA Korsana Biosciences, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Mar 25, 2025 | KRSA Korsana Biosciences, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Mar 25, 2025 | KRSA Korsana Biosciences, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Dec 17, 2024 | KRSA Korsana Biosciences, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Dec 17, 2024 | KRSA Korsana Biosciences, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
31 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:59 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances